Dr. Abdulhadi Mohammed Abdulwahed is an Assistant Professor of Clinical Laboratory Sciences at the College of Applied Medical Sciences, King Saud University (Riyadh, Saudi Arabia). He earned his PhD in Public Health (Environmental and Health Sciences) from Florida International University and an MSc in Cellular and Molecular Biology from the University of New Haven (USA). He also completed a certified program in Artificial Intelligence in Health Care at Harvard Medical School (2025).
His research focuses on molecular medicine, cancer biology, and translational diagnostics. Core interests include DNA damage and repair in chemotherapy response, oxidative stress assessment via the comet assay, gold nanoparticle biosensor development for cancer biomarker detection, and the application of artificial intelligence to clinical diagnostics and precision oncology. His work spans cancer biomarkers (ovarian, bladder, hepatocellular carcinoma), environmental toxicology and carcinogenesis, and molecular epidemiology of infectious diseases.
He has published in journals including Nature Protocols, Viruses, Vaccines, BMC Infectious Diseases, and the International Journal of Molecular Sciences. He holds active research funding from King Saud University. He serves as Supervisor of the Scientific Research Unit at his college, leading graduate mentorship, research governance, and international collaboration.
Dr. Abdulhadi Mohammed Abdulwahed is an Assistant Professor of Clinical Laboratory Sciences at the College of Applied Medical Sciences, King Saud University (Riyadh, Saudi Arabia). He earned his PhD in Public Health (Environmental and Health Sciences) from Florida International University and an MSc in Cellular and Molecular Biology from the University of New Haven (USA). He also completed a certified program in Artificial Intelligence in Health Care at Harvard Medical School (2025).
His research focuses on molecular medicine, cancer biology, and translational diagnostics. Core interests include DNA damage and repair in chemotherapy response, oxidative stress assessment via the comet assay, gold nanoparticle biosensor development for cancer biomarker detection, and the application of artificial intelligence to clinical diagnostics and precision oncology. His work spans cancer biomarkers (ovarian, bladder, hepatocellular carcinoma), environmental toxicology and carcinogenesis, and molecular epidemiology of infectious diseases.
He has published in journals including Nature Protocols, Viruses, Vaccines, BMC Infectious Diseases, and the International Journal of Molecular Sciences. He holds active research funding from King Saud University. He serves as Supervisor of the Scientific Research Unit at his college, leading graduate mentorship, research governance, and international collaboration.